Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT01130766
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed non-small cell lung cancer with synchronous brain metastases (diagnosis of brain lesion before or within 2 months from diagnosis of the primary site tumor)
* One to 4 intraparenchymal brain metastases by contrast-enhanced MRI, meeting the following criteria:
1. Well circumscribed tumor(s) with brain edema Grade 0-1
2. Maximum diameter ≤ 3.0 cm
* No prior complete resection of all known brain metastases or RT ④ No leptomeningeal metastases by MRI or cerebrospinal fluid evaluation
* Patients without any symptoms or signs from brain metastases (RTOG neurologic functions status of 0) ⑥ Age, 18 and over ⑦ ECOG performance status 0-1 ⑧ Written informed consent
Exclusion Criteria:
* severe co-morbid illness and/or active infections ② pregnant or lactating women
* RTOG neurologic function status of 1\~4 ④ Uncontrollable extracranial metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01130766
Study Brief:
Protocol Section:
NCT01130766